Starpharma Holdings Limited (ASX:SPL)
Australia flag Australia · Delayed Price · Currency is AUD
0.7850
-0.0250 (-3.09%)
Sep 10, 2026, 4:10 PM AEST

Starpharma Holdings Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
12.6712.675.859.764.345.16
Revenue Growth
-13.10%116.55%-40.04%124.64%-15.87%48.04%
Gross Profit
0.770.77-3.73-0.93-8.02-9.29
Operating Income
-7.47-7.47-9.99-8.17-15.64-16.15
Net Income
-7.47-7.47-9.99-8.17-15.64-16.15
Earnings Per Share
-0.02-0.02-0.02-0.02-0.04-0.04
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
11.0211.0215.4123.3635.1849.92
Total Debt
0.710.712.43.538.278.19
Net Cash (Debt)
10.3110.3113.0119.8326.9141.73
Net Cash Growth
-40.96%-20.74%-34.42%-26.30%-35.52%-29.67%
Net Cash Per Share
0.020.020.030.050.070.10

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-3.21-3.21-6.76-6.98-14.31-13.16
Capital Expenditures
-0.29-0.29-0.04-0.09-0.62-0.84
Free Cash Flow
-3.5-3.5-6.8-7.07-14.93-14
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
6.11%6.11%-63.74%-9.52%-184.57%-180.05%
Operating Margin
-58.93%-58.93%-170.77%-83.69%-360.07%-312.94%
Pretax Margin
-58.93%-58.93%-170.77%-83.69%-360.07%-312.94%
Profit Margin
-58.93%-58.93%-170.77%-83.69%-360.07%-312.94%
FCF Margin
-27.61%-27.61%-116.26%-72.43%-343.82%-271.19%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
311.9434.9434.9434.9434.9434.94
PS Ratio
29.5523.266.294.0129.3058.55